Article

AMO launches second phaco platform this year

The availability of a new cataract surgery platform from Abbott Medical Optics (AMO) marks the second phacoemulsification system launched by the company in the United States this year.

Las Vegas-The availability of a new cataract surgery platform from Abbott Medical Optics (AMO) marks the second phacoemulsification system launched by the company in the United States this year.

The Whitestar Signature Pro System provides a versatile solution designed to improve cataract surgeons’ efficiencies in the operating room, and to provide an excellent fit for their practice’s unique clinical demands and adaptability to meet their future needs, according to the company.

In addition to its on-demand fluidics and ultrasound efficiency, the system provides new analytics with the Cataract Analysis and Settings Application (CASA). The mobile analytics tool delivers performance metrics for the phacoemulsification procedure directly to an iPad device to aid the surgeon or administrator in managing the surgical suite.

 

The phacoemulsification platform “is designed for versatility and high-quality performance, allowing surgeons to easily optimize both their procedures and productivity, while simplifying their workflow in the operating room," said Leonard Borrmann, divisional vice president, research and development, Abbott.

Aside from this system, the company also launched its Compact Intuitiv System in April.

 

 

 

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
© 2025 MJH Life Sciences

All rights reserved.